Research Paper Volume 13, Issue 11 pp 15400—15412
Longitudinal trajectories of metabolic syndrome on different neurocognitive domains: a cohort study from the Taiwan biobank
Figure 2. Kaplan-Meier curves for the cumulative risk of cognitive decline in participants with and without metabolic syndrome (MetS). Different cognitive evaluations include: (A) Mild cognitive impairment (MCI) (p = 0.007) (B) Dementia (p = 0.002) (C) Decline in orientation (p < 0.001) (D) Decline in registration (p = 0.195) (E) Decline in concentration (p = 0.565) (F) Decline in memory recall (p = 0.583) (G) Decline in language (p = 0.006) (H) Decline in visuospatial (p = 0.001).